Evidence map›Paper›PMID 40543808›Full record

ReviewBiochimica et biophysica acta. Molecular and cell biology of lipids2025

PI(4,5)P

Masaki Yamaga, Thomas F J Martin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biochimica et biophysica acta. Molecular and cell biology of lipids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Masaki YamagaDepartment of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA. Electronic address: yamaga@wisc.edu.
Thomas F J MartinDepartment of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA. Electronic address: tfmartin@wisc.edu.

Funding

THE MECHANISM OF ACTION OF THYROTROPIN-RELEASING HORMONER01DK025861 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MARTIN, THOMAS F. J. · 1986 to 2024
$5.6M
CA++ REGULATION OF SECRETION IN NEUROENDOCRINE CELLSR01DK040428 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MARTIN, THOMAS F. J. · 1988 to 2015
$4.8M
THE MECHANISM OF ACTION OF THYROTROPIN-RELEASING HORMONER37DK025861 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MARTIN, THOMAS F. J. · 1991 to 2008
$3.3M
Calcium Regulation of Secretion in Neuroendocrine CellsR01GM119158 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARTIN, THOMAS F. J. · 2016 to 2019
$1.3M
NIDDK NIH HHS R01 DK025861NIDDK NIH HHS R01 DK040428NIDDK NIH HHS R37 DK025861NIGMS NIH HHS R01 GM119158
6 · The paper itself

Abstract

Substantial evidence indicates that phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P

Indexed as

CalciumExocytosisPhosphatidylinositol 4,5-DiphosphateAnimalsHumansMembrane FusionSNARE ProteinsCalciumPhosphatidylinositol 4,5-DiphosphateSNARE ProteinsCAPS1/CADPSMunc13–1/ubMunc13–2Phosphatidylinositol (4,5)-bisphosphatePI(4,5)P(2)-binding effector proteinSNARE proteinSynaptotagmin-1Vesicle exocytosis

Identifiers

PMID40543808
PMCPMC12341446

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.